AEON Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
Aeon Biopharma Inc (AEON) is not a strong buy at this moment for a beginner investor with a long-term strategy. The stock lacks clear positive catalysts, has weak financial performance, and no significant trading signals or trends to support immediate investment. Holding off for now is recommended.
The MACD is slightly positive and contracting, indicating weak momentum. RSI is neutral at 41.37, showing no overbought or oversold conditions. Moving averages are bullish (SMA_5 > SMA_20 > SMA_200), but the price is below the pivot level of 1.16, with key support at 0.954 and resistance at 1.366.
NULL identified. No recent news or trading trends to support a positive outlook.
The stock price has declined significantly (-5.22% in the regular market), and financial performance is weak with declining net income (-26.46% YoY) and EPS (-96.53% YoY). No significant hedge fund or insider activity.
In Q3 2025, revenue remained at 0 with no growth. Net income dropped to -$4,538,000 (-26.46% YoY), and EPS fell to -0.39 (-96.53% YoY). Gross margin remained at 0 with no improvement.
No data available for analyst ratings or price target changes.
